Research and Markets: Hormone Replacement Therapy (HRT) – Global Strategic Business Report

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/2dd8e6/hormone_replacemen) has announced the addition of the "Hormone Replacement Therapy (HRT) - Global Strategic Business Report" report to their offering.

This report analyzes the worldwide markets for Hormone Replacement Therapy (HRT) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. A six-year historic analysis is also provided for these markets.

The Report Profiles 42 Companies Including Many Key and Niche Players Such As:

Bayer HealthCare Pharmaceuticals, Inc. Besins Healthcare SA Hisamitsu Pharmaceutical Co. Inc. Noven Pharmaceuticals Inc. Mylan Canada Novartis AG Novo Nordisk A/S Orion Corporation Pfizer Inc. Wyeth Pharmaceuticals Inc. Rottapharm SpA Teva Pharmaceutical Industries Ltd. Thramex Warner Chilcott Watson Pharmaceuticals Inc.

Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Key Topics Covered:

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

2. INDUSTRY OVERVIEW

3. MARKET TRENDS

4. PRODUCT OVERVIEW

5. RECENT INDUSTRY ACTIVITY

6. FOCUS ON SELECT KEY PLAYERS

7. GLOBAL MARKET PERSPECTIVE

8. THE UNITED STATES

9. CANADA

10. EUROPE

11. ASIA-PACIFIC

12. REST OF WORLD

For more information visit http://www.researchandmarkets.com/research/2dd8e6/hormone_replacemen

Continued here:
Research and Markets: Hormone Replacement Therapy (HRT) - Global Strategic Business Report